Complications: Urgent C Section VS Elective C Section

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Hadassah Medical Organization.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01524107
First received: January 30, 2012
Last updated: NA
Last verified: January 2012
History: No changes posted
  Purpose

The medical literature does not provide sufficient information or recommendation regarding specific antibiotic coverage for urgent Caesarian sections. The goal of this study is to compare maternal and neonatal morbidity of women who have undergone urgent Caesarian Sections for Prolapsed Cord to those who have undergone Elective Caesarian Sections in order to develop a standard treatment protocol. The Medical Record review will include many parameters including complications, type of antibiotic usage etc.


Condition
Urgent Caesarian Section Secondary to Cord Prolapse

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Comparison of Maternal and Fetal Complications After Urgent Caesarian Section for Prolapsed Cord Versus Elective Caesarian Section.

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 240
Study Start Date: January 2012
Groups/Cohorts
Urgent Caesarian Section
Elective Caesarian Section

  Eligibility

Ages Eligible for Study:   20 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Women undergoing Urgent Caesarian Section for Prolapsed Cord and women undergoing Elective Caesarian Section at Hadassah Medical Center-Har HaTzofim.

Criteria

Inclusion Criteria:

  • women undergoing urgent Caesarian Section for Prolapsed Cord.
  • women undergoing Elective Caesarian Section.

Exclusion Criteria:

  • preterm birth
  • multiple gestation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01524107

Contacts
Contact: Drorith Hochner-Celnikier, MD 00 972 2 5844400 hochner@hadassah.org.il

Locations
Israel
Hadassah Medical Organization Recruiting
Jerusalem, Israel
Contact: Hadas Lemberg, PhD    00 972 2 6777572    lhadas@hadassah.org.il   
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Drorith Hochner-Celnikier, MD Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01524107     History of Changes
Other Study ID Numbers: CSURGENT-ELECT-HMO-CTIL
Study First Received: January 30, 2012
Last Updated: January 30, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
Prophylaxis Antibiotics
Maternal Complications
Neonatal Complications
Cord Prolapse
Elective Caesarian Section
Maternal Morbidity
Neonatal Morbidity

Additional relevant MeSH terms:
Prolapse
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on October 20, 2014